gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex

Journal of Cell Science

Volumn 108, Issue 6, 1995, Pages 2361-2368

  Stefansson, S ^a   Kounnas, M Z ^a   Henkin, J ^a   Mallampalli, R K ^a   Chappell, D A ^a   Strickland, D K ^a   Argraves, W S ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Endocytosis; Fibrinolysis; Low density lipoprotein receptor family

Indexed keywords

GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCLONAL ANTIBODY; PROTEINASE; PROUROKINASE; UROKINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME DEGRADATION; ENZYME REGULATION; FETUS; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; LIGAND BINDING; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; TUMOR CELL LINE;

ANIMAL; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; ENDOCYTOSIS; EPITHELIAL CELLS; EPITHELIUM; HEYMANN NEPHRITIS ANTIGENIC COMPLEX; HUMAN; LUNG; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RADIOLIGAND ASSAY; RATS; RECEPTORS, LDL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; URINARY PLASMINOGEN ACTIVATOR;

EID: 0028998813     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)